Because exercise reduces the risk of developing cardiovascular diseases, the CDC advises Americans to engage in a minimum of 30 minutes of moderate physical activities such as brisk walking, gardening, or vacuuming five days per week, or vigorous physical activities such as running, aerobics, or heavy yard work three days per week. While more than half of the U.S. population fails to meet CDC recommendations, low physical activity among adult survivors of ALL may further increase this group’s already high risk for obesity, cardiovascular disease and mortality, researchers said.
Though the addition of CRT to ALL therapy over 40 years ago led to a marked increase in survival rates, research has since linked CRT to reduced cognitive function, hormonal imbalance and obesity. In some patients, CRT may cause loss of postural and motor control, balance, and/or muscle weakness, which may lead to decreased physical activity.
Because of the risks associated with CRT and the availability of improved chemotherapy drugs to treat ALL, CRT is now only used to treat children with particularly aggressive forms of ALL. According to Dr. Oeffinger, approximately 10 to 15 percent of ALL patients today are treated with CRT.
Although childhood cancer patients are less likely to receive CRT than they were 20 years ago, Dr. Oeffinger says modern chemotherapy for ALL may also lead to decreased levels of physical activity, and needs further study. To reduce the long-term negative effects of chemotherapy on childhood cancer survivors, researchers hope to teach children and their families healthy lifestyle habits early, so they can carry them into adulthood.
“The storyline is that physical inactivity and obesity outcomes are based upon type of therapy administered to patient,” said Dr. Oeffinger. “Importantly, there are things we can do to intervene and to help childhood cancer survivors to regain active lifestyles that will protect the patient in the long run.”
###
This research was funded by the Department of Health and Human Services, the Children’s Cancer Research Fund, the American Lebanese Syrian Associated Charities, and the University of Rochester School of Medicine.
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes nearly 26,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 70 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy. |